A study co-authored by the Healthcare Delivery Research Program staff examines the connection between depression and pain severity in women cancer survivors. Early assessment of psychosocial factors could be key to managing pain effectively. Learn more: https://lnkd.in/eFN5pT8D
NCI Division of Cancer Control and Population Sciences
Government Administration
Rockville, MD 2,338 followers
Advancing science to improve public health
About us
As NCI’s bridge to public health research, practice, and policy, the Division of Cancer Control and Population Sciences (DCCPS) plays a unique role in reducing the burden of cancer in America. DCCPS has the lead responsibility at NCI for supporting research in surveillance, epidemiology, health services, behavioral science, and cancer survivorship. The division also plays a central role within the federal government as a source of expertise and evidence on issues such as the quality of cancer care, the economic burden of cancer, geographic information systems, statistical methods, communication science, comparative effectiveness research, obesity, tobacco control, and the translation of research into practice. NCI Privacy Policy: https://www.cancer.gov/policies/privacy-security
- Website
-
https://cancercontrol.cancer.gov/
External link for NCI Division of Cancer Control and Population Sciences
- Industry
- Government Administration
- Company size
- 51-200 employees
- Headquarters
- Rockville, MD
- Founded
- 1997
- Specialties
- Cancer control, Cancer research, population science, grants, funding, survivorship, epidemiology, behavioral research, tobacco control, cancer screening, healthcare delivery, implementation science, cancer statistics, and cancer trends
Updates
-
NCI seeks input by June 17, 2024, from those with cohorts of individuals with germline genotyping and/or sequencing and cancer follow-up data on the feasibility of an NCI-sponsored study of multi-cancer detection test performance among people at high genetic risk for cancer. NCI invites feedback on the topics listed below. Interest in participating in an NCI-led ancillary study to evaluate MCD test performance among people at high genetic risk for cancer. Description of the study population(s) available, including study design and inclusion/exclusion criteria. Description of germline testing, including assay(s) used, and availability of data from germline testing. Total number of cancer cases in the study population. Total number of individuals without cancer in the study population. Number of individuals with a hereditary cancer syndrome (e.g. Lynch syndrome, HBOC) and the specific hereditary cancer syndromes represented in the study population, if known. Number of individuals without a hereditary cancer syndrome in the study population, if known. Availability, if any, of banked blood specimens collected via Cell-Free DNA Collection Tubes. Availability, if any, of banked plasma specimens processed and frozen within 1 hour of collection. See the Request for Information (RFI) at https://lnkd.in/eNxWfTTd. Please submit comments to NCI_DCCPS_MCD@nih.gov and include the RFI number (NOT-CA-24-051) in the subject line of your email.
-
Join NCCOR on June 4–5 for the Obesity-Related Policy, Systems, and Environmental Research in the U.S. (OPUS) workshop! Featuring presentations from leading obesity prevention and public health experts, the workshop will examine best practices in obesity prevention research with specific attention to community engagement and systems change through an equity lens. The workshop aims to advance the field by highlighting opportunities for the design and rigorous evaluation of both proximal and distal policy, systems, and environmental (PSE) interventions. Register for the OPUS workshop here: https://shorturl.at/hDEWX. Questions? Contact Meher Din at mdin@fhi360.org
-
New funding opportunity: Interventions to Reduce Sleep Health Disparities. DCCPS aims to support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce disparities. https://lnkd.in/eTguXcAy
-
Assessing and offering people with cancer stepped collaborative care may help better manage symptoms of depression, pain, and fatigue than the standard referral to providers for treatment, according to a recent study. https://go.nih.gov/2QwsfEn
Approach Integrates Cancer Symptom Management into Routine Care
cancer.gov
-
From JAMA: Researchers used the Cancer Intervention and Surveillance Modeling Network (CISNET), which relies on data from the Surveillance, Epidemiology, and End Results (SEER) Program, to explore the benefits and costs of new breast cancer screening strategies. Read: CISNET modeling steered new breast cancer screening guidelines https://lnkd.in/etCeUa7c #CancerResearch #BreastCancer #CancerScreening #Mammograms
-
Cancer researchers, did you know you can do your own analyses using our public-use cancer data sets and tools? Check out our resources for you here: https://lnkd.in/eR5JsGpw
-
The Healthcare Delivery Research Program (HDRP) has extended its search for Chief of the Healthcare Assessment Research Branch! Open through 5/24, we are seeking applicants with experience in population-based research related to providing cancer screening, treatment, and survivorship. Potential applicants will also need to demonstrate experience in providing scientific leadership in planning, development, and direction of an integrated program of health services research to address cancer burden. Learn more about the position and apply today! https://go.nih.gov/wAjtuSN
Chief, Healthcare Assessment Research Branch
healthcaredelivery.cancer.gov
-
Join us for a Cancer Moonshot Conversation on Thursday, May 23, at 12:00 pm ET! Dr. Kai Tan of the Children's Hospital of Philadelphia and Liz Salmi, a PE-CGS Network investigator and advocate, will discuss how the #CancerMoonshot is advancing #DataSharing https://lnkd.in/dHxBYng
-
NCI, in partnership with the Department of Veterans Affairs (VA) and other Health and Human Services agencies, led a consensus-building process with subject matter experts to develop the National Standards for Cancer Survivorship Care. This effort was undertaken as part of the Biden Cancer Moonshot and the President’s Cancer Cabinet. NCI’s DCCPS also announced an administrative supplement Notice of Special Interest (NOSI) to encourage current awardees to apply for additional funds to support research with an overall goal of examining and improving survivorship care to align with these recently developed National Standards for Cancer Survivorship Care. For more information about the new National Standards for Cancer Survivorship Care, the associated publication in the Journal of Cancer Survivorship, and the NOSI, go to https://go.nih.gov/RrC6hci. #SurvivorshipCare #CancerCare #SurvOnc